Bank Of New York Mellon Corp Alector, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$5.69 - $8.08 $120,975 - $171,788	21,261 Added 10.17%	230,313 $1.39 Billion
Q4 2023 Jan 29, 2024	SELL	$3.77 - $8.39 $86,495 - $192,491	-22,943 Reduced 9.89%	209,052 $1.67 Billion
Q3 2023 Oct 24, 2023	SELL	$5.2 - $8.77 $14,435 - $24,345	-2,776 Reduced 1.18%	231,995 $1.5 Billion
Q2 2023 Aug 03, 2023	BUY	$5.86 - $7.93 $150,508 - $203,674	25,684 Added 12.28%	234,771 $1.41 Billion
Q1 2023 May 09, 2023	BUY	$5.85 - $9.84 $1.22 Million - $2.06 Million	209,087 New	209,087 $1.29 Billion
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $1.46 Million - $2.02 Million	211,778 New	211,778 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $158,337 - $255,195	19,333 Added 9.47%	223,551 $2.12 Million
Q2 2022 Aug 15, 2022	SELL	$7.65 - $14.24 $18,956 - $35,286	-2,478 Reduced 1.2%	204,218 $2.08 Million
Q1 2022 May 11, 2022	BUY	$13.02 - $20.78 $25,818 - $41,206	1,983 Added 0.97%	206,696 $2.95 Million
Q4 2021 Feb 11, 2022	BUY	$19.35 - $25.54 $396,520 - $523,365	20,492 Added 11.12%	204,713 $4.23 Million
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $343,693 - $626,903	15,875 Added 9.43%	184,221 $4.2 Million
Q2 2021 Aug 11, 2021	SELL	$15.5 - $22.48 $216,457 - $313,933	-13,965 Reduced 7.66%	168,346 $3.51 Million
Q1 2021 May 13, 2021	SELL	$14.84 - $22.23 $86,680 - $129,845	-5,841 Reduced 3.1%	182,311 $3.67 Million
Q4 2020 Feb 09, 2021	SELL	$9.4 - $16.7 $4.73 Million - $8.41 Million	-503,436 Reduced 72.79%	188,152 $2.85 Million
Q3 2020 Nov 12, 2020	SELL	$10.54 - $24.96 $3.05 Million - $7.22 Million	-289,119 Reduced 29.48%	691,588 $7.29 Million
Q2 2020 Aug 12, 2020	BUY	$21.87 - $33.11 $14.3 Million - $21.6 Million	653,640 Added 199.85%	980,707 $24 Million
Q1 2020 May 06, 2020	BUY	$16.25 - $35.28 $3.58 Million - $7.76 Million	220,056 Added 205.64%	327,067 $7.89 Million
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $284,533 - $407,624	20,080 Added 23.1%	107,011 $1.84 Million
Q3 2019 Nov 07, 2019	BUY	$14.42 - $22.2 $789,855 - $1.22 Million	54,775 Added 170.34%	86,931 $1.25 Million
Q2 2019 Aug 12, 2019	BUY	$16.26 - $26.42 $313,850 - $509,958	19,302 Added 150.16%	32,156 $611,000
Q1 2019 May 14, 2019	BUY	$15.97 - $22.5 $205,278 - $289,215	12,854 New	12,854 $241,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account